Integrated Investment Consultants’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-4,758
Closed -$264K – 360
2025
Q1
$264K Hold
4,758
– – 0.05% 271
2024
Q4
$229K Sell
4,758
-97
-2% -$4.93K 0.05% 274
2024
Q3
$280K Sell
4,855
-550
-10% -$29.7K 0.06% 247
2024
Q2
$263K Hold
5,405
– – 0.07% 213
2024
Q1
$263K Buy
+5,405
New +$264K 0.07% 213
2018
Q2
– Sell
-214
Closed -$9K – 615
2018
Q1
$9K Buy
+214
New +$8.9K ﹤0.01% 652

Other funds holding SNY

Integrated Investment Consultants's SNY Position: Q2 2025 in Review

Integrated Investment Consultants sold out of Sanofi (SNY) in Q2 2025, closing a stake of 4,758 shares — an estimated $264K sold.

Integrated Investment Consultants first reported a position in SNY in Q1 2018 and held it in 6 quarters. The position peaked at $280K in Q3 2024. 731 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • Integrated Investment Consultants reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • Integrated Investment Consultants sold 4,758 Sanofi shares in Q2 2025, an estimated $264K.
  • Integrated Investment Consultants first reported a position in Sanofi in Q1 2018 and held it in 6 quarters.
  • Integrated Investment Consultants's Sanofi position peaked at $280K in Q3 2024.
  • 731 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Integrated Investment Consultants's 13F filing for Q2 2025, filed 14 Aug 2025.